What is Taxotere®?
Taxotere® is a chemotherapy medication that is widely used to treat various forms of cancer by targeting and slowing cancerous cells. Most commonly, it has been prescribed to over a million patients with breast cancer, with a vast majority of them being women.
Taxotere® Side Effects and Complications
The chemotherapy drug, Taxotere®, has been linked to persistent or permanent hair loss.
Although many people who undergo chemotherapeutic medications expect temporary hair loss, they are told that it should grow back after treatment has ended. Unfortunately, for many people who have taken Taxotere®, this is not the reality.
Cancer patients have reported signs of alopecia, a condition which results in the permanent loss of hair all over the body, including…
- Head hair
- Beard and mustache hair
- Underarm hair
- Pubic hair
For more information: 11/24/15 FDA Label Change – Taxotere® to include permanent or irreversible alopecia
Taxotere® Lawsuit Lawyers Fighting the Drug Company
A diagnosis of breast cancer is devastating. Losing hair temporarily due to chemotherapy adds to the devastation because it publicizes a very personal and private matter that the person is experiencing. When hair loss is permanent, the indelible mark of cancer remains, adversely affecting the feelings of complete physical and emotional recovery.
If you have taken Taxotere® and now suffer from permanent hair loss, you may be entitled to compensation for:
- Emotional trauma
- Psychological damage
- Associated expenses
- Punitive damages (to punish the wrongdoers and discourage future behavior)
It is suspected that Sanofi-Aventis hid the side effect of permanent hair loss in an attempt to boost sales in the highly competitive field of breast cancer medications. Studies show that there are comparable medications that can be used to treat breast cancer that do not have the side effect of persistent or permanent hair loss.
When Sanofi-Aventis did not warn oncologists that Taxotere® or Docetaxel® can cause permanent hair loss, they eliminated the potential of a patient’s full consent to use this medication. Without the full knowledge of the adverse effects, patients were unable to make informed decisions about their choices of treatment and their management of care.
Over 8,000 lawsuits have been filed against Sanofi-Aventis and other manufacturers by patients who were given Taxotere® or Docetaxel® to treat cancer and have now been left with permanent hair loss. Several cases are set for trial in 2019.
Contact Us for Your Hair Loss Lawsuit
The manufacturers who are liable for your suffering will undoubtedly try to get out of paying damages, which is why you need a skilled and aggressive team of attorneys on your side.
We have a long track record of success in obtaining compensation on behalf of clients, including nationally recognized verdicts and settlements in mass tort cases. Contact us today to get started.